Trial intelligence / Profile preview

Rivastigmine for tardive dyskinesia

IRCT2012092910964N1Phase 3Completed

Sponsor
University of Social Welfare and Rehabilitation Sciences
Start
Oct 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of rivastigmine in tardive dyskinesia (TD), sponsored by University of Social Welfare and Rehabilitation Sciences. Started Oct 2011; status: completed.

02

Drugs

rivastigmine
03

Conditions

tardive dyskinesia (TD)

Beyond the preview

Go deeper on IRCT2012092910964N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012092910964N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call